Glaxo (GSK), Theravance (THRX) Report Anoro Ellipta Receives Reimbursement Approval by Australian PBS
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) have welcomed news that Anoro Ellipta (umeclidinium/vilanterol) will be reimbursed via the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
